Deutsche Bank Ag\ Kazia Therapeutics LTD Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$7.35 - $12.0 $654 - $1,068	-89 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$9.1 - $14.71 $18 - $29	-2 Reduced 2.2%	89 $1,000
Q1 2021 May 13, 2021	BUY	$8.98 - $12.86 $817 - $1,170	91 New	91 $1,000
Q1 2020 May 14, 2020	SELL	$2.72 - $4.64 $816 - $1,392	-300 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.84 - $7.4 $852 - $2,220	300 New	300 $1,000

2.13M

93.2K

Ticker KZIA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,111,300
Market Cap $87.5M
Description
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.